| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 24, 2007
Accepted on December 26, 2007
Clinical and Experimental Dermatology/Department of Biomedical Sciences, University of Bradford, UK; Institute for Pigmentary Disorders in Association with the EM Arndt University Greifswald, Germany, and U of Bradford, UK; Department of Dermatology, University of Münster, Germany
* To whom correspondence should be addressed. E-mail: k.schallreuter{at}bradford.ac.uk.
The Ca2+-dependent precursor convertase furin is abundantly expressed in epidermal keratinocytes and melanocytes. In this context it is noteworthy that proopiomelanocortin (POMC) cleavage is also processed by furin leading to ACTH,
-LPH, and
-endorphin. All prohormone convertases including furin are regulated by Ca2. Since numerous epidermal peptides and enzymes are affected by H2O2-mediated oxidation, including the POMC derived peptides
-MSH and
-endorphin as shown in the epidermis of patients with vitiligo, we here asked the question whether furin could also be a possible target for this oxidation mechanism by using immunofluorescence, RT-PCR, Western blotting, Ca2+ binding studies, and computer modelling. Our results demonstrate significantly decreased in situ immunoreactivity of furin in the epidermis of patients with progressive vitiligo (n=10) suggesting H2O2-mediated oxidation. This was confirmed by [45Ca2+] binding studies with human recombinant furin identifying the loss of one Ca2+-binding site from the enzyme after oxidation with H2O2. Computer simulation supported alteration of one of the two Ca2+-binding sites on furin. Taken together, our results implicate that the Ca2+ dependent proteolytic activity of this convertase is targeted by H2O2 which in turn could contribute to the reduced epidermal expression of the POMC-derived peptides
-MSH and
-endorphin as documented earlier in patients with vitiligo.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |